Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2025-08-19 00:00:00 ET · period of report 2025-08-15 · accession 0001601830-25-000132 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-19 | 2025-08-15 | RXRX | Gibson Christopher | CEO, Dir | F - Tax | $5.64 | -40.4K | 954.2K | -4% | -$227.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-08-15 | F | D | 40,390 | $5.64 | 954,229 | D | — | — |